Management of Fungal Infections Complicating Granulocytopenia

Implications for Patients With Radiation Injuries
  • Thomas J. Walsh
  • Philip A. Pizzo


Invasive fungal infections are common complications reported with increasing frequency in granulocytopenic patients. These invasive mycoses cause substantial morbidity and mortality in patients receiving aggressive cytotoxic chemotherapy and ablative radiation therapy. The problem of invasive mycoses is further complicated by the appearance of new fungal pathogens and increasing reports of emerging resistance to established antifungal compounds. The two most common fungal groups infecting granulocytopenic patients are Candida species and Aspergillus species.


Fungal Infection Candida Species Invasive Aspergillosis Invasive Mycosis Aspergillus Species 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Walsh, T. J., and Pizzo, P. A. Nosocomial fungal infections. Annu Rev Microbiol 42: 517–545, 1988.PubMedCrossRefGoogle Scholar
  2. 2.
    Epstein, J., Truelove, E., and lzutzu, K. Oral candidiasis: Pathogenesis and host defense. Rev Infect Dis 6: 96–106, 1984.PubMedCrossRefGoogle Scholar
  3. 3.
    Holst, E. Natamycin and nystatin for treatment of oral candidiasis during and after radiotherapy. J Prosthet Dent 51: 226–231, 1984.PubMedCrossRefGoogle Scholar
  4. 4.
    Quintiliani, R., Owens, N. J., Quercia, R., et al. Treatment and prevention of oropharyngeal candidiasis. Am J Med 77 (4D): 44–48, 1984.PubMedGoogle Scholar
  5. 5.
    Rodu, B., Griffin, I., and Gockerman, J. Oral candidiasis in cancer patients. South Med J 77: 312–314, 1984.Google Scholar
  6. 6.
    Walsh, T. J., and Grey, W. Candida epiglottitis in immunocompromised patients. Chest 9: 482–485, 1987.CrossRefGoogle Scholar
  7. 7.
    Schechtman, S., Fumaro, L., Robin, T., et al. Clotrimazole treatment of oral candidiasis in patients with neoplastic disease. Am J Med 76: 91–94, 1984.CrossRefGoogle Scholar
  8. 8.
    Meunier, F., Gerain, J., Snoeck, R., et al. Fluconazole therapy of oropharyngeal candidiasis in cancer patients. In: Recent Trends in the Discovery, Development, and Evaluation of Antifungal Agents. R. Fromtling, Ed. R. J. Prous Science, Barcelona, Spain, 1988, pp. 169–174.Google Scholar
  9. 9.
    Sanford, G. R., Merz, W. G., Wingard, J. R., et al. The value of fungal surveillance cultures as predictors of systemic fungal infections.) Infect Dis 142: 503–509, 1980.CrossRefGoogle Scholar
  10. 10.
    Kramer, B. S., Pizzo, P. A., Robichaud, K. J., et al. Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia. Am J Med 72: 561–568, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Walsh, T. J., Newman, K. R., Moody, M., et al. Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore) 65: 268–279, 1986.CrossRefGoogle Scholar
  12. 12.
    Aisner, J., Murillo, J., Schimpff, S. C., et al. Invasive aspergillosis in acute leukemia: Correlation with nose cultures and antibiotic use. Ann Intern Med 90: 4–9, 1979.Google Scholar
  13. 13.
    Treger, T. R., Visscher, D. W., Bartlett, M. S., et al. Diagnosis of pulmonary infection caused by Aspergillus: Usefulness of respiratory cultures. J Infect Dis 152: 572–576, 1975.CrossRefGoogle Scholar
  14. 14.
    Yu, V. L., Muder, R. R., and Poosattar, A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Am J Med 81: 249–254, 1986.PubMedCrossRefGoogle Scholar
  15. 15.
    Pizzo, P. A., Robichaud, K. J., Gill, F. A., et al. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 72: 101–110, 1982.PubMedCrossRefGoogle Scholar
  16. 16.
    Thaler, M., Pastakia, B., Shawker, T. H., et al. Hepatic candidiasis in cancer patients: The evolving picture of the syndrome. Ann Intern Med 108: 88–100, 1988.PubMedCrossRefGoogle Scholar
  17. 17.
    Paros, R. J., Barr, L. F., Walsh, T. J., et al. Factors associated with fatal hemoptysis in cancer patients. Chest 94: 1008–1013, 1988.CrossRefGoogle Scholar
  18. 18.
    Walsh, T. J., Caplan, L. R., and Hier, D. B. Aspergillus infections of the central nervous system: A clinicopathological analysis. Ann Neurol 18: 574–582, 1985.PubMedCrossRefGoogle Scholar
  19. 19.
    Burch, P. A., Karp, J. B., and Merz, W. G. Favorable outcome of invasive Aspergillus in patients with acute leukemia. J Clin Oncol 5: 1985–1993, 1987.PubMedGoogle Scholar
  20. 20.
    Horn, R., Wong, B., Koehn, T. B., et al. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 7: 646–655, 1985.PubMedCrossRefGoogle Scholar
  21. 21.
    Walsh, T. J., and Pizzo, P. A. Treatment of systemic fungal infections: Recent progress and current problems. Eur J Clin Microbiol 7: 460–475, 1988.Google Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Thomas J. Walsh
    • 1
  • Philip A. Pizzo
    • 1
  1. 1.Section of Infectious DiseasesPediatric Branch, National Cancer InstituteBethesdaUSA

Personalised recommendations